PDE4 inhibition: a novel approach for the treatment of inflammatory bowel disease: Trends in Pharmacological Sciences
Design, synthesis, and biological evaluation of novel catecholopyrimidine based PDE4 inhibitor for the treatment of atopic dermatitis - ScienceDirect
Targeting PDE4 as a promising therapeutic strategy in chronic ulcerative colitis through modulating mucosal homeostasis - ScienceDirect
Molecules | Free Full-Text | An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Inhibition of PDE4B suppresses inflammation by increasing expression of the deubiquitinase CYLD | Nature Communications
Action of PDE4 inhibitors can prolong or enhance effects of cAMP and... | Download Scientific Diagram
Reducing Neuroinflammation in Psychiatric Disorders: Novel Target of Phosphodiesterase 4 (PDE4) and Developing of the PDE4 Inhibitors | IntechOpen
PDE4 inhibitors in COPDFa more selective approach to treatment
Otezla Mechanism of Action (MOA) — PDE4 Inhibitor | Otezla® (apremilast) Healthcare Professional Site
Advances in the Development of Phosphodiesterase-4 Inhibitors | Journal of Medicinal Chemistry
File:Mechanism of action of PDE4 inhibitor.jpg - Wikimedia Commons
Schematic representation of how Phosphodiesterase 4 (PDE4) inhibitors,... | Download Scientific Diagram
Frontiers | Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
Phosphodiesterase inhibitor - Wikipedia
PDE4 as Therapeutic Targets in Different Diseases | Encyclopedia MDPI
The effect and associated mechanism of action of phosphodiesterase 4 (PDE4) inhibitor on CD4+ lymphocyte proliferation - Kim - 2021 - Clinical and Experimental Pharmacology and Physiology - Wiley Online Library
IJMS | Free Full-Text | PDE4 Inhibition and Inflammatory Bowel Disease: A Novel Therapeutic Avenue
FCPR03 is a Selective Phosphodiesterase 4 (PDE4) Inhibitor - Immune System Research
Targeted Delivery of an Anti-inflammatory PDE4 Inhibitor to Immune Cells via an Antibody–drug Conjugate: Molecular Therapy
An Overview of PDE4 Inhibitors in Clinical Trials | Encyclopedia MDPI
PDE4 subtypes in cancer | Oncogene
Figure 1 from Apremilast : a novel PDE 4 inhibitor in the treatment of autoimmune and inflammatory diseases | Semantic Scholar
Phosphodiesterase-4 (PDE4) inhibitors have the potential to suppress... | Download Scientific Diagram
The role of phosphodiesterase 4 in the pathophysiology of atopic dermatitis and the perspective for its inhibition - Guttman‐Yassky - 2019 - Experimental Dermatology - Wiley Online Library
GSK356278 is a Selective and Orally Bioavailable PDE4 Inhibitor - Immune System Research
Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity | Reumatología Clínica
Potent PDE4 inhibitor activates AMPK and Sirt1 to induce mitochondrial biogenesis | PLOS ONE
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
